Search Results

1 - 10 of 537 items :

  • "development" x
Clear All
Development and evaluation of carvedilol transdermal patches

. Landsberg and J. B. Young, Physiology and Pharmacology of the Autonomic Nervous System , in Harrison's Principles of Internal Medicine (Eds. E. Braunwald, A. S. Fanci, D. L. Kasper, S. L. Hauser, D. L. Longo and J. L. Janeson), 15 th ed., Mc. Graw Hill, New York 2001, p. 447. U. V. Singh, S. Pandey and N. Udupa, Preparation and evaluation of flurbiprofen and diclofenac sodium transdermal films, Indian J. Pharm. Sci. 54 (1993) 145-147. P. Arora and B. Mukherjee, Design, development, physicochemical, and in vitro

Open access
Development and in vitro evaluation of buccoadhesive carvedilol tablets

. Frier and C. G. Wilson, Design and Evaluation of Sustained Release Formulations for Oral and Buccal Administration, in Controlled Release Nitroglycerine in Buccal and Oral Form (Eds. W. D. Bussmann, R. R. Dries and W. Wagner, Karger, Basle 1982, pp. 17-25. T. S. Owens, R. J. Dansereau and A. Sakr, Development and evaluation of extended release bioadhesive sodium fluoride tablets, Int. J. Pharm. 288 (2005) 109-122; DOI: 10.1016/j.ijpharm.2004. 09.017. J. Akbari, A. Nokhodchi, D. Farid, M. Adrangui, M. R. Siahi

Open access
Liquisolid systems and aspects influencing their research and development

development of solid solution formulation of itraconazole for enhancement of drug dissolution and bioavailability, Int. J. Pharm. 229 (2001) 193-203; DOI: 10.1016/S0378-5173(01)00867-5. 15. D. X. Li, Y. Oh, S. Lim, J. O. Kim, H. J. Yang, J. H. Sung, C. S. Yong and H. Choi, Novel gelatin microcapsule with bioavailability enhancement of ibuprofen using spray-drying technique, Int.J. Pharm. 355 (2008) 277-284; DOI: 10.1016/j.ijpharm.2007.12.020. 16. V. Stella, J. Haslam, N. Yata, H. Okada, S. Lindenbaum and T. Higuchi, Enhancement of

Open access
Development of hydroxyapatite-ciprofloxacin bone-implants using »Quality by design«

, Potential use of gelacasting hydroxyapatite porous ceramic as an implantable drug delivery system, Int. J. Pharm.   213 (2001) 117-125; DOI: 10.1016/S0378-5173(00)00659-1. B. D. Shenoy, N. Udupa and A. Nagarajkumari, Implantable drug delivery systems for centochromon, Indian J. Pharm. Sci.   59 (1997) 246-250. W. Zafirau, D. Parker, W. Billotte and P. K. Bajpai, Development of a ceramic device for the continuous local delivery of steroids, Biomed. Sci. Instrum.   32 (1996) 63-70. A. K

Open access
Development of a radiolabeled β-human chorionic gonadotropin

. Rowshanfarzad, K. Shafaii, M. Kamali-Dehghan, J. Moafian, M. Akhlaghi, M. Babai, S. Rajabifar and M. Mirzaii, Development of 111In-DTPA-human polyclonal antibody complex for long-term inflammation/infection detection, Nukleonika 50 (2005) 91-96. P. G. Righetti, G. Tudor and K. Ek, Isoelectric points and molecular weights of proteins, J. Chromatogr. 220 (1981) 115-194. A. J. Ziecik, M. M. Kaczmarek, A. Blitek, A. E. Kowalczyk, X. Li and N. A. Rahman, Novel biological and possible applicable roles of LH/hCG receptor, Mol

Open access
Development and validation of a UPLC-MS method for determination of atazanavir sulfate by the “analytical quality by design” approach

. Murthy and S. K. Panda, Development and validation of a stability-indicating RP–HPLC method for estimation of atazanavir sulfate in bulk, J. Pharm. Anal. 7 (2017) 134–140; 9. C. H. Bhirud and S. N. Hiremath, Stability indicating RP-HPLC method for the determination of atazanavir sulphate in bulk and dosage form, Drug Invent. Today 5 (2013) 81–86; 10. L. Else, V. Watson, J. Tjia, A. Hughes, M. Siccardi, S. Khoo and D. Back, Validation of a rapid and sensitive high

Open access
Development and optimization of metoprolol succinate gastroretentive drug delivery system

References B. N. Singh and K. H. Kim, Floating drug delivery systems: an approach to oral controlled drug delivery via gastric retention, J. Control. Rel.   63 (2000) 235-259. S. Arora, J. Ali, A. Ahuja, R. K. Khar and S. Baboota, Floating drug delivery systems: a review, AAPS PharmSciTech   6 (2005) 372-390. R. Bomma, R. A. S. Naidu, M. R. Yamsani and K. Veerabrahma, Development and evaluation of gastroretentive norfloxacin floating tablets, Acta Pharm.   59 (2009) 211

Open access
Development and evaluation of gastroretentive norfloxacin floating tablets

Delivery to the Gastrointestinal Tract , in Polymeric Site-Specific Pharmacotherapy (Ed. A. J. Domb), Wiley, Chichester 1994, pp. 283--285. W. A. Ritschel, Targeting in the gastrointestinal tract: new approaches, Methods Find, Exp. Clin. Pharmacol. 13 (1991) 313--316. C. Mahesh, J. Paras, C. Sachin, S. Rajesh and V. Pradeep, Development of sustained release gastroretentive drug delivery system for ofloxacin: in vitro and in vivo evaluation, Int. J. Pharm. 304 (2005) 178--184; DOI: 10.1016/j.ijpharm.2005

Open access
Formulation and pharmaceutical development of quetiapine fumarate sustained release matrix tablets using a QbD approach

References 1. D. Sahu and A. Rana, Formulation development of Quetiapine Fumarate SR matrix tablets, Der Pharm. Sin. 1 (2010) 48-57. 2. S. Cheer and A. Wagstaff, Quetiapine. A review of its use in the management of schizophrenia, CNS Drugs 18 (2004) 173-199; DOI: 10.2165/00023210-200418030-00004. 3. G. Garbacz, A. Kandzi, M. Koziolek, J. Mazgalski and W. Weitschies, Release characteristics of quetiapine fumarate extended release tablets under biorelevant stress test conditions

Open access
Formulation development of oral controlled release tablets of hydralazine: Optimization of drug release and bioadhesive characteristics

compreshensive computer program for study of drug release kinetics from compressed matrices, Indian J. Pharm. Sci.   60 (1998) 313-316. B. Singh, T. Kaur and S. Singh, Correction of raw dissolution data for loss of drug during sampling, Indian J. Pharm. Sci.   59 (1997) 196-199. R. W. Korsemeyer, R. Gurny, E. Doelker, P. Buri and N. Peppas, Mechanisms of solute release from porous hydrophilic polymers, Int. J. Pharm.   15 (1983) 23-35. B. Singh and N. Ahuja, Development of controlled

Open access